Early encounters with palliative care (PC) can influence health-care utilization, clinical outcome, and cost.
Aim:
To study the effect of timing of PC encounters on brain metastasis patients at an academic medical center.
Setting/Participants:
All patients diagnosed with brain metastases from January 2013 to August 2015 at a single institution with inpatient and/or outpatient PC records available for review (N = 145).
Design:
Early PC was defined as having a PC encounter within 8 weeks of diagnosis with brain metastases; late PC was defined as having PC after 8 weeks of diagnosis. Propensity score matched cohorts of early (n = 46) and late (n = 46) PC patients were compared to control for differences in age, gender, and Karnofsky Performance Status (KPS) at diagnosis. Details of the palliative encounter, patient outcomes, and health-care utilization were collected.
Results:
Early PC versus late PC patients had no differences in baseline KPS, age, or gender. Early PC patients had significantly fewer number of inpatient visits per patient (1.5 vs 2.9; P = .004), emergency department visits (1.2 vs 2.1; P = .006), positron emission tomography/computed tomography studies (1.2 vs 2.7, P = .005), magnetic resonance imaging scans (5.8 vs 8.1; P = .03), and radiosurgery procedures (0.6 vs 1.3; P < .001). There were no differences in overall survival (median 8.2 vs 11.2 months; P = .2). Following inpatient admissions, early PC patients were more likely to be discharged home (59% vs 35%; P = .04).
Conclusions:
Timely PC consultations are advisable in this patient population and can reduce health-care utilization.
DeVitaVTLawrenceTSRosenbergSA. DeVita, Hellman, and Rosenberg’s cancer: Principles & Practice of Oncology. 9th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011.
2.
CairncrossJGKimJHPosnerJB. Radiation therapy for brain metastases. Ann Neurol. 1980;7(6):529–541.
3.
WongJHirdAKirou–MauroANapolskikhJChowE. Quality of life in brain metastases radiation trials: a literature review. Curr Oncol. 2008;15(5):25–45.
4.
PatchellRA. The management of brain metastases. Cancer Treat Rev. 2003;29(6):533–540.
5.
DamiensKAyoubJPLemieuxB. Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution. Curr Oncol. 2012;19(5):254–258.
6.
SchuetteW. Treatment of brain metastases from lung cancer: chemotherapy. Lung Cancer. 2004;45(suppl 2):S253–S257.
7.
NiederCNorumJStemlandJGDalhaugA. Resource utilization in patients with brain metastases managed with best supportive care, radiotherapy and/or surgical resection: a markov analysis. Oncology. 2010;78(5-6):348–355.
8.
BeccaroMCostantiniMGiorgi RossiPMiccinesiGGrimaldiMBruzziP. Actual and preferred place of death of cancer patients. Results from the Italian survey of the dying of cancer (ISDOC). J Epidemiol Community Health. 2006;60(5):412–416.
9.
HigginsonIJSen-GuptaGJ. Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med. 2000;3(3):287–300.
10.
RocqueGBBarnettAEIlligLC. Inpatient hospitalization of oncology patients: are we missing an opportunity for end-of-life care?J Oncol Pract. 2013;9(1):51–54.
11.
SmithTJHillnerBE. Bending the cost curve in cancer care. N Engl J Med. 2011;364(21):2060–2065.
12.
Somogyi-ZaludEZhongZHamelMBLynnJ. The use of life-sustaining treatments in hospitalized persons aged 80 and older. J Am Geriatr Soc. 2002;50(5):930–934.
13.
BakitasMLyonsKDHegelMT. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009;302(7):741–749.
14.
BakitasMATostesonTDLiZ. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1438–1445.
15.
TemelJSGreerJAMuzikanskyA. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–742.
16.
ParikhRBKirchRASmithTJTemelJS. Early specialty palliative care—translating data in oncology into practice. N Engl J Med. 2013;369(24):2347–2351.
17.
MayPGarridoMMCasselJB. Prospective cohort study of hospital palliative care teams for inpatients with advanced cancer: earlier consultation is associated with larger cost-saving effect. J Clin Oncol. 2015;33(25):2745–2752.
18.
BrumleyREnguidanosSJamisonP. Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care. J Am Geriatr Soc. 2007;55(7):993–1000.
19.
GadeGVenohrIConnerD. Impact of an inpatient palliative care team: a randomized control trial. J Palliat Med. 2008;11(2):180–190.
20.
ParisJMorrisonRS. Evaluating the effects of inpatient palliative care consultations on subsequent hospice use and place of death in patients with advanced GI cancers. J Oncol Pract. 2014;10(3):174–177.
21.
RogersJGPatelCBMentzRJ. Palliative care in heart failure: the PAL-HF randomized, controlled clinical trial. J Am Coll Cardiol. 2017;70(3):331–341.
22.
CarsonSSCoxCEWallensteinS. Effect of palliative care-led meetings for families of patients with chronic critical illness: a randomized clinical trial. JAMA. 2016;316(1):51–62.
23.
KondziolkaDCooperBTLunsfordLDSilvermanJ. Development, implementation, and use of a local and global clinical registry for neurosurgery. Big Data. 2015;3(2):80–89.
24.
WeylandMSFellermannHHadornM. The MATCHIT automaton: exploiting compartmentalization for the synthesis of branched polymers. Comput Math Methods Med. 2013;2013:467428.
25.
HoDEImaiKKingGStuartEA. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42(8):1–28.
26.
QuanHSundararajanVHalfonP. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139.
27.
SperdutoPWChaoSTSneedPK. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys. 2010;77(3):655–661.
28.
KhandelwalNBrumbackLCHalpernSDCoeNBBrumbackBCurtisJR. Randall. evaluating the economic impact of palliative and end-of-life care interventions on intensive care unit utilization and costs from the hospital and healthcare system perspective. J Palliat Med. 2017;20(12):1314–1320.
29.
EarleCCLandrumMBSouzaJMNevilleBAWeeksJCAyanianJZ. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?J Clin Oncol. 2008;26(23):3860–3866.
30.
AgrawalMEmanuelEJ. Attending to psychologic symptoms and palliative care. J Clin Oncol. 2002;20(3):624–626.
31.
ScibettaCKerrKMcguireJRabowMW. The costs of waiting: implications of the timing of palliative care consultation among a cohort of decedents at a comprehensive cancer center. J Palliat Med. 2016;19(1):69–75.
32.
CheungMCEarleCCRangrejJ. Impact of aggressive management and palliative care on cancer costs in the final month of life. Cancer. 2015;121(18):3307–3315.
33.
KimHRajagopalanMSBeriwalSSmithKJ. Cost-effectiveness analysis of stereotactic radiosurgery alone versus stereotactic radiosurgery with upfront whole brain radiation therapy for brain metastases. Clin Oncol (R Coll Radiol). 2017;29(10):e157–e164.
34.
HalaszLMUnoHHughesM. Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer. Cancer. 2016;122(13):2091–2100.
35.
KhandelwalNBrumbackLCHalpernSDCoeNBBrumbackBCurtisJR. Evaluating the economic impact of palliative and end-of-life care interventions on intensive care unit utilization and costs from the hospital and healthcare system perspective. J Palliat Med. 122017;20(12):1314–1320.
